Mogrify Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 68
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $20M
Latest Deal Amount
  • Investors
  • 8

Mogrify General Information

Description

Developer of a cellular technology platform intended to transform cell therapy via direct cellular conversion. The company's platform is powered by sequencing and gene-regulatory data to identify the optimal combination of transcription factors or small molecules, enabling researchers to address the issues of efficacy, safety, and scalability which is currently associated with cell therapy development and manufacturing.

Contact Information

Website
www.mogrify.co.uk
Formerly Known As
Cell Mogrify
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Healthcare Technology Systems
Primary Office
  • Bio-Innovation Centre
  • 25 Cambridge Science Park
  • Cambridge CB4 0FW
  • England, United Kingdom
+44 01223 000000

Mogrify Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Mogrify Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A) 04-May-2021 $20M 000.00 00000 Completed Generating Revenue
5. Grant 28-Jan-2020 00.00 000.00 Completed Generating Revenue
4. Later Stage VC (Series A) 14-Oct-2019 000.00 000.00 0000 Completed Generating Revenue
3. Grant 18-Mar-2019 00000 00.000 Completed Generating Revenue
2. Seed Round 20-Feb-2019 $4M $4.38M Completed Generating Revenue
1. Seed Round 16-Dec-2016 $376K $376K 00.000 Completed Startup
To view Mogrify’s complete valuation and funding history, request access »

Mogrify Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
B Ordinary 000 00.000000 00000 00000 00 00000 0.000
C Ordinary 0,000 00.000000 00000 00000 00 00000 00.000
C Ordinary 000 00.000000 00000.00 00000.00 00 00000.00 0.000
B Ordinary 000 00.000000 00000.00 00000.00 00 00000.00 0.000
C Ordinary 000 00.000000 00000.00 00000.00 00 00000.00 0.000
B Ordinary 00 00.000000 00000.00 00000.00 00 00000.00 0.00
C Ordinary 000 00.000000 00000.00 00000.00 00 00000.00 0.000
B Ordinary 000 00.000000 0000.00 0000.00 00 0000.00 0.00
B Ordinary 420 $0.001240 $354.26 $354.26 1x $354.26 4.95%
B Ordinary 70 $0.001240 $531.39 $531.39 1x $531.39 0.82%
To view Mogrify’s complete cap table history, request access »

Mogrify Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a cellular technology platform intended to transform cell therapy via direct cellular conversion. The compa
Drug Discovery
Cambridge, United Kingdom
68 As of 2021
000.00
0000 0000-00-00
00000000000 000.00

00000000

r adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad min
0000 000000000
New York, NY
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

00000000

et, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
0000000000000
Tucson, AZ
00 As of 0000
000.00
0000 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mogrify Competitors (23)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neurogene Venture Capital-Backed New York, NY 00 00000 00000000000 00000
000000000 Formerly VC-backed Tucson, AZ 00 000.00 000000&0 000.00
0000000 Corporation London, Canada 00 000.00 00000000 000.00
0000000 0000000000 Formerly VC-backed Brisbane, CA 000 0000 00000000 0000
000000000000 00000 Venture Capital-Backed Madison, WI 00.000 0000000000 0 00.000
You’re viewing 5 of 23 competitors. Get the full list »

Mogrify Patents

  • 12

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

Mogrify Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3067863-A1 Cell reprogramming to cardiomyocytes Pending 21-Jun-2017 0000000000
JP-2020524518-A Cell reprogramming into cardiomyocytes Pending 21-Jun-2017 0000000000
EP-3642328-A1 Cell reprogramming to cardiomyocytes Pending 21-Jun-2017 0000000000
AU-2018286654-A1 Cell reprogramming to cardiomyocytes Pending 21-Jun-2017 0000000000
EP-3642328-A4 Cell reprogramming to cardiomyocytes Pending 21-Jun-2017 C12N5/0657 0
To view Mogrify’s complete patent history, request access »

Mogrify Executive Team (8)

Name Title Board Seat Contact Info
Darrin Disley Chief Executive Officer & Board Member
Joe Foster Chief Operating Officer
Owen Rackham Co-Founder & Chief Technology Officer
Louise Modis Ph.D Chief Scientific Officer
Helen Glen Financial Controller
You’re viewing 5 of 8 executive team members. Get the full list »

Mogrify Board Members (13)

Name Representing Role Since
Alastair Kilgour Parkwalk Advisors Board Member 000 0000
Darrin Disley Mogrify Chief Executive Officer & Board Member 000 0000
Hiromichi Kimura Ph.D Astellas Venture Management Board Observer 000 0000
Jane Osbourn Ph.D Self Chairman 000 0000
Joanna Green Ph.D Self Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Mogrify Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mogrify Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Astellas Venture Management Corporate Venture Capital Minority 000 0000 000000 0
SBRI Healthcare Government 000 0000 000000 0
Jonathan Milner Angel (individual) Minority 000 0000 000000 0
Parkwalk Advisors Venture Capital Minority 000 0000 000000 0
University of Bristol Endowment Limited Partner Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Mogrify Subsidiaries (1)

Company Name Industry Location Founded
000000000000 Biotechnology Cambridge, United Kingdom 0000
To view Mogrify’s complete subsidiaries history, request access »